Kinaxis (TSE:KXS) Given New C$190.00 Price Target at TD Securities

Kinaxis (TSE:KXSFree Report) had its price target trimmed by TD Securities from C$195.00 to C$190.00 in a report published on Friday, BayStreet.CA reports. The brokerage currently has a buy rating on the stock.

KXS has been the subject of a number of other reports. Scotiabank reduced their price target on shares of Kinaxis from C$200.00 to C$190.00 in a research report on Thursday, August 29th. Stifel Nicolaus reduced their price target on shares of Kinaxis from C$210.00 to C$195.00 and set a “buy” rating for the company in a research report on Friday, August 2nd. Finally, ATB Capital reduced their price target on shares of Kinaxis from C$215.00 to C$205.00 and set an “outperform” rating for the company in a research report on Friday, August 2nd. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of C$192.67.

Read Our Latest Report on KXS

Kinaxis Price Performance

TSE KXS traded up C$11.36 on Friday, reaching C$166.00. The company’s stock had a trading volume of 135,366 shares, compared to its average volume of 66,911. Kinaxis has a twelve month low of C$132.93 and a twelve month high of C$172.83. The company has a debt-to-equity ratio of 12.40, a quick ratio of 2.29 and a current ratio of 1.90. The stock has a market cap of C$4.69 billion, a PE ratio of 166.00, a PEG ratio of 3.60 and a beta of 0.78. The firm’s 50 day moving average is C$155.24 and its two-hundred day moving average is C$154.29.

Kinaxis (TSE:KXSGet Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported C$0.47 earnings per share for the quarter, beating analysts’ consensus estimates of C$0.43 by C$0.04. Kinaxis had a net margin of 4.59% and a return on equity of 4.87%. The company had revenue of C$165.79 million during the quarter, compared to the consensus estimate of C$170.56 million. As a group, sell-side analysts predict that Kinaxis will post 4.2526231 EPS for the current year.

Insider Activity

In other news, Senior Officer Andrew William Robert Bell sold 701 shares of the company’s stock in a transaction dated Wednesday, August 14th. The stock was sold at an average price of C$149.56, for a total value of C$104,841.70. Following the completion of the sale, the insider now directly owns 831 shares of the company’s stock, valued at C$124,284.53. This represents a 0.00 % decrease in their position. In related news, Senior Officer Megan Paterson sold 3,172 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of C$156.28, for a total value of C$495,720.16. Following the completion of the transaction, the insider now directly owns 121 shares in the company, valued at approximately C$18,909.88. The trade was a 0.00 % decrease in their position. Also, Senior Officer Andrew William Robert Bell sold 701 shares of the business’s stock in a transaction that occurred on Wednesday, August 14th. The shares were sold at an average price of C$149.56, for a total value of C$104,841.70. Following the completion of the transaction, the insider now owns 831 shares of the company’s stock, valued at C$124,284.53. This represents a 0.00 % decrease in their ownership of the stock. Insiders sold a total of 8,265 shares of company stock valued at $1,268,146 in the last ninety days. 1.20% of the stock is owned by insiders.

About Kinaxis

(Get Free Report)

Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.

Featured Stories

Analyst Recommendations for Kinaxis (TSE:KXS)

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.